A detailed history of Northwestern Mutual Wealth Management CO transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 12 shares of PYXS stock, worth $16. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12
Holding current value
$16
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$1.54 - $4.77 $18 - $57
12 New
12 $0
Q2 2024

Aug 15, 2024

BUY
$3.06 - $5.58 $765 - $1,395
250 New
250 $0

Others Institutions Holding PYXS

About Pyxis Oncology, Inc.


  • Ticker PYXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,096,400
  • Market Cap $47.7M
  • Description
  • Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...
More about PYXS
Track This Portfolio

Track Northwestern Mutual Wealth Management CO Portfolio

Follow Northwestern Mutual Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.